Patient-derived organoids and neurospheres recapitulate salient features of primary tumor heterogeneity
Open Access
- 22 November 2025
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 8 (1)
Abstract
Background: The intra- and inter-tumoral heterogeneity of glioblastoma (GBM) represents a significant therapeutic challenge and barrier to the generation of reliable and accurate models for in vitro studies. Three-dimensional models, such as patient-derived neurospheres (PDN) and organoids (PDO), recapitulate complex cellular states. However, the direct comparison of models derived in parallel from the same primary tumor tissue has never been performed. The aim of this study was to determine the tumor cell composition of PDN and PDO models relative to matched primary GBM tissue. Methods: Four GBM surgical samples were used to establish matched PDO and PDN models, which were genomically verified using single nucleotide polymorphism array. DNA methylation, histology, and transcriptome were examined for intra-tumoral heterogeneity correlating with the matched GBM tissue. PDN lines were used to investigate the tumor cell composition response to temozolomide chemotherapy over time, maximizing their utility. Results: We find that both patient-derived models recapitulate the genomic, epigenomic, and tumor cell heterogeneity of the primary tissue at similar capacity. Furthermore, single-nuclei RNA sequencing revealed a subset of organoids containing small numbers of non-malignant cells from neuron and immune cell lineages. Harnessing the intra-tumoral heterogeneity of PDN models, we reveal the impact of temozolomide chemotherapy on individual cell states, altering composition of tumors over time in response to treatment. Conclusions: Our data confirms that both PDN and PDO patient-derived models recapitulate patient intra-tumoral heterogeneity providing a platform for tumor cell state refined therapeutic studies.Keywords
Funding Information
- Brain Cancer Centre
This publication has 48 references indexed in Scilit:
- Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugsNature Methods, 2016
- Computational assignment of cell-cycle stage from single-cell transcriptome dataMethods, 2015
- HOX genes and their role in the development of human cancersJournal of Molecular Medicine, 2014
- Temozolomide: Mechanisms of Action, Repair and ResistanceCurrent Molecular Pharmacology, 2012
- Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapyNeurology, 2011
- Allele-specific copy number analysis of tumorsProceedings of the National Academy of Sciences, 2010
- Neurosphere Formation Is an Independent Predictor of Clinical Outcome in Malignant GliomaStem Cells, 2009
- The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroidsOncogene, 2007
- Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell linesCancer Cell, 2006
- MGMTGene Silencing and Benefit from Temozolomide in GlioblastomaNew England Journal of Medicine, 2005